Resonate Blends Executes a Share Exchange Agreement With Emergent Health Corp.

Resonate Blends, Inc. (OTCQB:KOAN) announced the completion of a Share Exchange Agreement with Emergent Health Corp. (OTC Pink:EMGE), finalizing the deal on March 14, 2024. Following the agreement, Resonate Blends will rebrand to Apollo Biowellness, Inc., transitioning into a focus on regenerative medicine destined primarily for doctor's offices and clinics, alongside public sales. Apollo Biowellness now encompasses subsidiaries like Evolutionary Biologics, Integrative Practice Solutions LLC, Juventix Regenerative Medical LLC, and the impending Maximus Mean's Health. The entity aims to disrupt the $5.6 trillion Global Health & Wellness Market, asserting a prominent position in the $20.04 billion regenerative medicine market, with projections to reach $125.54 billion by 2030.

The restructured company will offer products across the Personal Care, Beauty, and Anti-Aging markets, pursuing FDA approvals for specific regenerative treatments. With over 700 independent sales reps and distribution partners, Apollo Biowellness projects substantial growth, exploiting synergies across its subsidiaries. Separately, Emergent Health will retain its subsidiary Wholistic Brands, focusing on plant-based health formulations. Jim Morrison, a notable figure in the personal care sector, assumes the role of Chairman and President/CEO of Apollo Biowellness, bringing extensive industry experience to the helm. The arrangement also results in the conveyance of Resonate Blends' previous assets back to its initial management.